-
2
-
-
0027920980
-
Pathogenetic mechanisms of septic shock
-
Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
-
(1993)
N Engl J Med
, vol.328
, pp. 1471-1477
-
-
Parrillo, J.E.1
-
3
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
-
Angus DC, Linde-Zwirble WT, Lidlicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
-
(2001)
Crit Care Med
, vol.29
, pp. 1303-1310
-
-
Angus, D.C.1
Linde-Zwirble, W.T.2
Lidlicker, J.3
-
6
-
-
0029864356
-
Nitric oxide and septic shock
-
Cobb J, Danner R: Nitric oxide and septic shock. JAMA 1996; 275:1192-1196
-
(1996)
JAMA
, vol.275
, pp. 1192-1196
-
-
Cobb, J.1
Danner, R.2
-
8
-
-
0028870359
-
L-arginine: Nitric oxide pathway in endotoxemia and human septic shock
-
Gomez-Jimenez J, Salgado M, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
-
(1995)
Crit Care Med
, vol.23
, pp. 253-258
-
-
Gomez-Jimenez, J.1
Salgado, M.2
Mourelle, M.3
-
10
-
-
0035070316
-
Indices of nitric oxide synthesis and outcome in critically ill patients
-
MacKenzie IM, Garrard CS, Young JD: Indices of nitric oxide synthesis and outcome in critically ill patients. Anaesthesia 2001; 56: 326-330
-
(2001)
Anaesthesia
, vol.56
, pp. 326-330
-
-
MacKenzie, I.M.1
Garrard, C.S.2
Young, J.D.3
-
11
-
-
0036345689
-
Oxidative stress in critically ill patients with systemic inflammatory response syndrome
-
Alonso de Vega JM, Diaz J, Serrano E, et al: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30:1782-1786
-
(2002)
Crit Care Med
, vol.30
, pp. 1782-1786
-
-
Alonso de Vega, J.M.1
Diaz, J.2
Serrano, E.3
-
12
-
-
0031747694
-
Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse
-
Rees DD, Monkhouse JE, Cambridge D, et al: Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol 1998; 124:540-546
-
(1998)
Br J Pharmacol
, vol.124
, pp. 540-546
-
-
Rees, D.D.1
Monkhouse, J.E.2
Cambridge, D.3
-
13
-
-
0030640878
-
Plasma nitric oxide in posttrauma critical illness: A function of "sepsis" and the physiological state severity classification quantifying the probability of death
-
Rixen D, Siegel JH, Espina N, et al: Plasma nitric oxide in posttrauma critical illness: A function of "sepsis" and the physiological state severity classification quantifying the probability of death. Shock 1997; 7:17-28
-
(1997)
Shock
, vol.7
, pp. 17-28
-
-
Rixen, D.1
Siegel, J.H.2
Espina, N.3
-
14
-
-
0027281557
-
Circulatory failure in septic shock: Nitric oxide, too much of a good thing?
-
Brady AL, Poole-Wilson PA: Circulatory failure in septic shock: Nitric oxide, too much of a good thing? Br Heart J 1993; 70:103-105
-
(1993)
Br Heart J
, vol.70
, pp. 103-105
-
-
Brady, A.L.1
Poole-Wilson, P.A.2
-
15
-
-
0025195627
-
G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide
-
G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-3632
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 3629-3632
-
-
Kilbourn, R.G.1
Gross, S.S.2
Jubran, A.3
-
16
-
-
0029973006
-
Nitric oxide as a mediator of reduced arterial responsiveness in septic patients
-
Tsuneyoshi I, Kanmura Y, Yoshimura N: Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med 1996; 24:1083-1086
-
(1996)
Crit Care Med
, vol.24
, pp. 1083-1086
-
-
Tsuneyoshi, I.1
Kanmura, Y.2
Yoshimura, N.3
-
17
-
-
0027477592
-
Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats
-
Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993; 264:H660-H663
-
(1993)
Am J Physiol
, vol.264
-
-
Hollenberg, S.M.1
Cunnion, R.E.2
Zimmerberg, J.3
-
18
-
-
0025147512
-
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
-
Julou-Schaeffer G, Gray GA, Fleming I: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259(4Pt2):H1038-H1043
-
(1990)
Am J Physiol
, vol.259
, Issue.4 PT2
-
-
Julou-Schaeffer, G.1
Gray, G.A.2
Fleming, I.3
-
20
-
-
0033558704
-
Effects of endotoxin on human myocardial contractility: Involvement of nitric oxide and peroxynitrite
-
Flesch M, Kilter H, Cremers B, et al: Effects of endotoxin on human myocardial contractility: Involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 1999; 33:1062-1070
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 1062-1070
-
-
Flesch, M.1
Kilter, H.2
Cremers, B.3
-
21
-
-
0036892344
-
Clinical review: Myocardial depression in sepsis and septic shock
-
Court O, Kumar A, Parrillo JE, et al: Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6:500-508
-
(2002)
Crit Care
, vol.6
, pp. 500-508
-
-
Court, O.1
Kumar, A.2
Parrillo, J.E.3
-
22
-
-
0031801139
-
Pathophysiology of cardiovascular dysfunction in septic shock
-
Parker MM: Pathophysiology of cardiovascular dysfunction in septic shock. New Horizons 1998; 6:130-138
-
(1998)
New Horizons
, vol.6
, pp. 130-138
-
-
Parker, M.M.1
-
23
-
-
0037142987
-
Association between mitochondrial dysfunction and severity and outcome of septic shock
-
Brealey D, Brand M, Hargreaves I: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223
-
(2002)
Lancet
, vol.360
, pp. 219-223
-
-
Brealey, D.1
Brand, M.2
Hargreaves, I.3
-
24
-
-
0242361793
-
Inhibition of mitochondrial respiration during early sepsis
-
Davies NA, Cooper CE, Stidwill R: Inhibition of mitochondrial respiration during early sepsis. Adv Exp Med Biol 2003; 530:725-736
-
(2003)
Adv Exp Med Biol
, vol.530
, pp. 725-736
-
-
Davies, N.A.1
Cooper, C.E.2
Stidwill, R.3
-
25
-
-
0029112368
-
Association of microvascular leakage with induction of nitric oxide synthase: Effects of nitric oxide synthase inhibitors in various organs
-
Laszlo F, Whittle BJ, Evans SM, et al: Association of microvascular leakage with induction of nitric oxide synthase: Effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol 1995; 283:47-53
-
(1995)
Eur J Pharmacol
, vol.283
, pp. 47-53
-
-
Laszlo, F.1
Whittle, B.J.2
Evans, S.M.3
-
26
-
-
0028927044
-
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction
-
Goode HF, Cowley HC, Walker BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
-
(1995)
Crit Care Med
, vol.23
, pp. 646-651
-
-
Goode, H.F.1
Cowley, H.C.2
Walker, B.E.3
-
27
-
-
0031963885
-
Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis
-
Doughty L, Carcillo JA, Kaplan S, et al: Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Crit Care Med 1998; 26:157-162
-
(1998)
Crit Care Med
, vol.26
, pp. 157-162
-
-
Doughty, L.1
Carcillo, J.A.2
Kaplan, S.3
-
28
-
-
0038790425
-
Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome
-
Mitaka C, Hirata Y, Yokoyama K, et al: Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock 2003; 19:305-309
-
(2003)
Shock
, vol.19
, pp. 305-309
-
-
Mitaka, C.1
Hirata, Y.2
Yokoyama, K.3
-
29
-
-
4444273012
-
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock
-
López A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
-
(2004)
Crit Care Med
, vol.32
, pp. 21-30
-
-
López, A.1
Lorente, J.A.2
Steingrub, J.3
-
30
-
-
0033843943
-
Hemoglo- bin solutions: Not just red blood cell substitutes
-
Creteur J, Sibbald W, Vincent J-L: Hemoglo- bin solutions: Not just red blood cell substitutes. Crit Care Med 2000; 28:3025-3034
-
(2000)
Crit Care Med
, vol.28
, pp. 3025-3034
-
-
Creteur, J.1
Sibbald, W.2
Vincent, J.-L.3
-
32
-
-
0034656852
-
Pyridoxalated hemoglobin polyoxyethylene: A nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock
-
Privalle C, Talarico T, Keng T, et al: Pyridoxalated hemoglobin polyoxyethylene: A nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock. Free Radical Biol Med 2000; 28:1507-1517
-
(2000)
Free Radical Biol Med
, vol.28
, pp. 1507-1517
-
-
Privalle, C.1
Talarico, T.2
Keng, T.3
-
33
-
-
0029958436
-
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution
-
Przybelski RJ, Daily EK, Kisicki JC, et al: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 1996; 24:1993-2000
-
(1996)
Crit Care Med
, vol.24
, pp. 1993-2000
-
-
Przybelski, R.J.1
Daily, E.K.2
Kisicki, J.C.3
-
34
-
-
0028026903
-
Acellular and cellular hemoglobin solutions as vasoconstrictive factor
-
Nakai K, Matsuda N, Amano M, et al: Acellular and cellular hemoglobin solutions as vasoconstrictive factor. Artif Cells Blood Immob Biotech 1994; 22:559-564
-
(1994)
Artif Cells Blood Immob Biotech
, vol.22
, pp. 559-564
-
-
Nakai, K.1
Matsuda, N.2
Amano, M.3
-
35
-
-
0028927402
-
Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats
-
Kida Y, Maeda M, Iwata S, et al: Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats. Artif Organs 1995; 19:117-128
-
(1995)
Artif Organs
, vol.19
, pp. 117-128
-
-
Kida, Y.1
Maeda, M.2
Iwata, S.3
-
36
-
-
0030903708
-
Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep
-
Bone HG, Schenarts PJ, Booke M, et al: Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit Care Med 1997; 25:1010-1018
-
(1997)
Crit Care Med
, vol.25
, pp. 1010-1018
-
-
Bone, H.G.1
Schenarts, P.J.2
Booke, M.3
-
37
-
-
0343974641
-
Effects of hemoglobin in sepsis
-
Vincent J-L Ed, Berlin, Springer-Verlag
-
Fischer SR, Bone HG, Traber DL: Effects of hemoglobin in sepsis. In: The Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Ed). Berlin, Springer-Verlag, 1997, pp 424-441
-
(1997)
The Yearbook of Intensive Care and Emergency Medicine
, pp. 424-441
-
-
Fischer, S.R.1
Bone, H.G.2
Traber, D.L.3
-
38
-
-
0030846133
-
Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) does not restore hypoxic pulmonary vasoconstriction in ovine sepsis
-
Fischer SR, Bone HG, Powell WC, et al: Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) does not restore hypoxic pulmonary vasoconstriction in ovine sepsis. Crit Care Med 1997; 25:1551-1559
-
(1997)
Crit Care Med
, vol.25
, pp. 1551-1559
-
-
Fischer, S.R.1
Bone, H.G.2
Powell, W.C.3
-
39
-
-
0031895705
-
Comparison of the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxemic sheep
-
Bone HG, Waurick R, Van Aken H, et al: Comparison of the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxemic sheep. Intensive Care Med 1998; 24:48-54
-
(1998)
Intensive Care Med
, vol.24
, pp. 48-54
-
-
Bone, H.G.1
Waurick, R.2
Van Aken, H.3
-
40
-
-
0011564617
-
Nitric oxide scavengers in sepsis
-
Fischer SR, Bone HG, Harada M, et al: Nitric oxide scavengers in sepsis. Sepsis 1998; 1:135-143
-
(1998)
Sepsis
, vol.1
, pp. 135-143
-
-
Fischer, S.R.1
Bone, H.G.2
Harada, M.3
-
41
-
-
0033224584
-
Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome
-
DeAngelo J: Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome. Exp Opin Pharmacother 1999; 1:19-29
-
(1999)
Exp Opin Pharmacother
, vol.1
, pp. 19-29
-
-
DeAngelo, J.1
-
42
-
-
0025945515
-
Nitrogen oxide levels in patients after trauma and during sepsis
-
Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
-
(1991)
Ann Surg
, vol.214
, pp. 621-626
-
-
Ochoa, J.B.1
Udekwu, A.O.2
Billiar, T.R.3
-
43
-
-
15844403223
-
Nitrite/ nitrate oxide (NOx) and cytokine levels in patients with septic shock
-
Endo S, Inada K, Nakae H, et al: Nitrite/ nitrate oxide (NOx) and cytokine levels in patients with septic shock. Res Comm Molec Pathol Pharmacol 1996; 91:347-356
-
(1996)
Res Comm Molec Pathol Pharmacol
, vol.91
, pp. 347-356
-
-
Endo, S.1
Inada, K.2
Nakae, H.3
-
44
-
-
4944221721
-
Implication of steady state concentrations of nitrite and nitrate metabolites of nitric oxide in plasma and whole blood in healthy human subjects
-
Himeno M, Ishibashi T, Nakano S, et al: Implication of steady state concentrations of nitrite and nitrate metabolites of nitric oxide in plasma and whole blood in healthy human subjects. Clin Exp Pharmacol Physiol 2004; 31:591-596
-
(2004)
Clin Exp Pharmacol Physiol
, vol.31
, pp. 591-596
-
-
Himeno, M.1
Ishibashi, T.2
Nakano, S.3
-
45
-
-
0025174741
-
Myocardial betaadrenergic receptor coupling to adenylate cyclase during developing septic shock
-
Jones SB, Romano FD: Myocardial betaadrenergic receptor coupling to adenylate cyclase during developing septic shock. Circ Shock 1990; 30:51-61
-
(1990)
Circ Shock
, vol.30
, pp. 51-61
-
-
Jones, S.B.1
Romano, F.D.2
-
46
-
-
0028868202
-
Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracyclinetreated patient
-
Ryding J, Heslte L, Hartvig T, et al: Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracyclinetreated patient. Chest 1995; 107:201-203
-
(1995)
Chest
, vol.107
, pp. 201-203
-
-
Ryding, J.1
Heslte, L.2
Hartvig, T.3
-
47
-
-
0030460346
-
Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS
-
Tighe D, Moss R, Bennett D: Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS. New Horizons 1996; 4:426-442
-
(1996)
New Horizons
, vol.4
, pp. 426-442
-
-
Tighe, D.1
Moss, R.2
Bennett, D.3
-
48
-
-
0030056373
-
Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia
-
van der Poll T, Coyle SM, Barbosa K, et al: Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97:713-719
-
(1996)
J Clin Invest
, vol.97
, pp. 713-719
-
-
van der Poll, T.1
Coyle, S.M.2
Barbosa, K.3
-
49
-
-
0034069083
-
Myocardial necrosis in ICU patients with acute noncardiac disease: A prospective study
-
Arlati S, Brenna S, Prencipe L, et al: Myocardial necrosis in ICU patients with acute noncardiac disease: A prospective study. Intensive Care Med 2000; 26:31-37
-
(2000)
Intensive Care Med
, vol.26
, pp. 31-37
-
-
Arlati, S.1
Brenna, S.2
Prencipe, L.3
-
50
-
-
0037638743
-
Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
-
Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41:2004-2009
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 2004-2009
-
-
Ammann, P.1
Maggiorini, M.2
Bertel, O.3
-
51
-
-
33646494316
-
Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides
-
Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129:1349-1366
-
(2006)
Chest
, vol.129
, pp. 1349-1366
-
-
Maeder, M.1
Fehr, T.2
Rickli, H.3
-
52
-
-
34248161572
-
First-generation blood substitutes: What have we learned? Biochemical and physiological perspectives
-
Alayash AI, DAgnillo F, Buehler PW: First-generation blood substitutes: What have we learned? Biochemical and physiological perspectives. Expert Opinion Biol Ther 2007; 7:665-675
-
(2007)
Expert Opinion Biol Ther
, vol.7
, pp. 665-675
-
-
Alayash, A.I.1
DAgnillo, F.2
Buehler, P.W.3
-
53
-
-
33845888257
-
Red cell substitutes
-
Winslow RM: Red cell substitutes. Semin Hematol 2007; 44:51-59
-
(2007)
Semin Hematol
, vol.44
, pp. 51-59
-
-
Winslow, R.M.1
-
54
-
-
0032112066
-
Continuous infusion of pyridoxalated hemoglobin polyoxyethylene conjugate in hyper-dynamic septic sheep
-
Bone HG, Fischer SR, Schenarts PJ, et al: Continuous infusion of pyridoxalated hemoglobin polyoxyethylene conjugate in hyper-dynamic septic sheep. Shock 1998; 10:69-76
-
(1998)
Shock
, vol.10
, pp. 69-76
-
-
Bone, H.G.1
Fischer, S.R.2
Schenarts, P.J.3
-
55
-
-
33747186373
-
DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats
-
Li Y, Li X, Haley M, et al: DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats. Intensive Care Med 2006; 32:1263-1270
-
(2006)
Intensive Care Med
, vol.32
, pp. 1263-1270
-
-
Li, Y.1
Li, X.2
Haley, M.3
-
56
-
-
34548174645
-
Risk of infection with intravenous iron therapy
-
Maynor L, Brophy DF: Risk of infection with intravenous iron therapy. Ann Pharmacother 2007; 41:1476-1480
-
(2007)
Ann Pharmacother
, vol.41
, pp. 1476-1480
-
-
Maynor, L.1
Brophy, D.F.2
-
57
-
-
0024323936
-
Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice
-
Schryvers AB, Gonzalez GC: Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infect Immun 1989; 57:2425-2429
-
(1989)
Infect Immun
, vol.57
, pp. 2425-2429
-
-
Schryvers, A.B.1
Gonzalez, G.C.2
|